Cargando…

Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts

BACKGROUND: Prostate cancer is a significant health problem among American men. Treatment strategies for androgen-independent cancer are currently not available. Tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) is a death receptor ligand that can induce apoptosis in a variety of...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Zawahry, Ahmed, McKillop, John, Voelkel-Johnson, Christina
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC546011/ https://www.ncbi.nlm.nih.gov/pubmed/15638938 http://dx.doi.org/10.1186/1471-2407-5-2

Ejemplares similares

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice
por: Hylander, Bonnie L, et al.
Publicado: (2005)

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis
por: Abdulghani, Junaid, et al.
Publicado: (2013)

PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L/TRAIL
por: Cheung, Vanessa, et al.
Publicado: (2013)

Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells
por: Zhang, Shuijun, et al.
Publicado: (2012)

Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2
por: Oishi, Masakatsu, et al.
Publicado: (2013)

Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey
por: Zuch de Zafra, Christina L, et al.
Publicado: (2016)

Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
por: Hagtvet, Eirik, et al.
Publicado: (2011)

Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)
por: Singh, Kamini, et al.
Publicado: (2014)

A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents
por: Arizono, Y, et al.
Publicado: (2003)

Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor
por: Ganapathy, Suthakar, et al.
Publicado: (2010)

Vitamin D Modulation of TRAIL Expression in Human Milk and Mammary Epithelial Cells
por: Sambandam, Yuvaraj, et al.
Publicado: (2017)

Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice
por: Ouyang, Jia, et al.
Publicado: (2021)

A Novel Role of IGF1 in Apo2L/TRAIL-Mediated Apoptosis of Ewing Tumor Cells
por: van Valen, Frans, et al.
Publicado: (2012)

Expression of Concern: Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor
Publicado: (2019)

Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice
por: MENG, XIANYING, et al.
Publicado: (2014)

TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE(-/-) Mice
por: Cartland, Siân P., et al.
Publicado: (2014)

The final energy crisis
por: McKillop, Andrew, et al.
Publicado: (2005)

Salt and marine products in the Classic Maya economy from use-wear study of stone tools
por: McKillop, Heather, et al.
Publicado: (2018)

Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
por: Shankar, Sharmila, et al.
Publicado: (2008)

Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
por: Bouralexis, S, et al.
Publicado: (2003)

Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer: Circularly permuted TRAIL with Dox in TNBC
por: Liu, Jia, et al.
Publicado: (2023)

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
por: Inoue, Takeshi, et al.
Publicado: (2013)

TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model
por: Fritsche, Hendrik, et al.
Publicado: (2015)

Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994)

Doxorubicin combined with low intensity ultrasound suppresses the growth of oral squamous cell carcinoma in culture and in xenografts
por: Fan, Haixia, et al.
Publicado: (2017)

Mechanism of Growth Inhibition of Prostate Cancer Xenografts by Valproic Acid
por: Sidana, Abhinav, et al.
Publicado: (2012)

Testosterone inhibits the growth of prostate cancer xenografts in nude mice
por: Song, Weitao, et al.
Publicado: (2017)

Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours
por: Pan, Y, et al.
Publicado: (2011)

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.
por: Boven, E., et al.
Publicado: (1992)

Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
por: McKillop, Aine M., et al.
Publicado: (2011)

A Broad Consideration of Risk Factors in Pediatric Chronic Pain: Where to Go from Here?
por: McKillop, Hannah N., et al.
Publicado: (2016)

Learning endometriosis phenotypes from patient-generated data
por: Urteaga, Iñigo, et al.
Publicado: (2020)

Sleep and ageing: from human studies to rodent models
por: McKillop, Laura E, et al.
Publicado: (2020)

MADD Knock-Down Enhances Doxorubicin and TRAIL Induced Apoptosis in Breast Cancer Cells
por: Turner, Andrea, et al.
Publicado: (2013)

Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase 3 in colon cancer cells
por: White-Gilbertson, S., et al.
Publicado: (2009)

Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death
por: Raimondo, Stefania, et al.
Publicado: (2015)

Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenografts
por: Liu, Y, et al.
Publicado: (2011)

Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
por: Zins, Karin, et al.
Publicado: (2013)

Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts
por: Santio, Niina M., et al.
Publicado: (2015)

TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity
por: Rossin, Aurélie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_re3ddct7e8uit450iqkvcaatpn